Provectus director granted Series D-1 preferred shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Provectus Biopharmaceuticals director Bailey Webster received a grant of 48,917 shares of Series D-1 Convertible Preferred Stock. The shares were acquired on June 30, 2026 at a stated price of $0.00 per share as a grant or award, not an open-market transaction.
Each share of Series D-1 Preferred Stock is convertible into 10 shares of Provectus common stock. The Series D-1 Preferred Stock will automatically convert into common stock on December 31, 2028, unless converted earlier under the terms of its Certificate of Designation. Following this grant, Webster directly holds 207,535 shares of Series D-1 Preferred Stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Series D-1 Convertible Preferred Stock | 48,917 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each share of Series D-1 Preferred Stock is convertible into 10 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock").
- F2. The Series D-1 Convertible Preferred Stock will automatically convert into Common Stock on December 31, 2028, unless earlier converted into Common Stock in accordance with the terms of the Certificate of Designation for the Series D-1 Convertible Preferred Stock.
Key Figures
Key Terms
Series D-1 Convertible Preferred Stock financial
automatic convert financial
Certificate of Designation regulatory
par value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Provectus Biopharmaceuticals (PVCT) disclose for Bailey Webster?
What is the conversion ratio for Provectus (PVCT) Series D-1 Convertible Preferred Stock?
When will Provectus (PVCT) Series D-1 Convertible Preferred Stock automatically convert?
Was Bailey Webster’s Provectus (PVCT) preferred stock transaction a purchase or a grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.